loadpatents
name:-0.0075888633728027
name:-0.037240028381348
name:-0.0012979507446289
Aberg; Gunnar Patent Filings

Aberg; Gunnar

Patent Applications and Registrations

Patent applications and USPTO patent grants for Aberg; Gunnar.The latest application filed is for "s-isomer of 2- piperidine and other dermal anesthetic agents".

Company Profile
0.12.6
  • Aberg; Gunnar - Sarosota FL
  • Aberg; Gunnar - Sarasota FL
  • Aberg; Gunnar - Westborough MA
  • Aberg; Gunnar - Lawrenceville NJ
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
Grant 8,062,627 - Aberg , et al. November 22, 2
2011-11-22
S-Isomer of 2- piperidine and Other Dermal Anesthetic Agents
App 20100179114 - Aberg; Gunnar ;   et al.
2010-07-15
Methods of relieving neuropathic pain with the S-isomer of 2-{2[N-(2-indanyl)-N-phenylamino]ethyl}piperidine
Grant 7,718,674 - Aberg May 18, 2
2010-05-18
Methods And Compositions For Treating Pulmonary Disorders Using Optically Pure (r,r)-formoterol
App 20080161411 - ABERG; Gunnar ;   et al.
2008-07-03
Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
Grant 7,368,120 - Aberg , et al. May 6, 2
2008-05-06
S-isomer of 2-{2[N-(2-indanyl)-N-phenylamino]ethyl}piperidine and other dermal anesthetics
App 20060079559 - Aberg; Gunnar ;   et al.
2006-04-13
R-isomer of 2-{2[N-(2-indanyl)-N-phenylamino]ethyl}piperidine and other dermal anesthetics
App 20060079558 - Aberg; Gunnar ;   et al.
2006-04-13
Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
App 20050131072 - Aberg, Gunnar ;   et al.
2005-06-16
Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
Grant 6,866,839 - Aberg , et al. March 15, 2
2005-03-15
Methods and compositions for treating pulmonary disorders using optically pure (R,R) -formoterol
App 20030203970 - Aberg, Gunnar ;   et al.
2003-10-30
Methods and compositions for treating pulmonary disorders using optically pure (R,R) formoterol
Grant 6,589,508 - Aberg , et al. July 8, 2
2003-07-08
Methods and compositions for treating pulmonary disorders using optically pure (R,R) formoterol
Grant 6,068,833 - Aberg , et al. May 30, 2
2000-05-30
NSAID/fluoride periodontal compositions and methods
Grant 5,807,541 - Aberg , et al. September 15, 1
1998-09-15
Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
Grant 5,795,564 - Aberg , et al. August 18, 1
1998-08-18
Methods and compositions for treating urinary incontinence using optically pure (S)-oxybutynin
Grant 5,736,577 - Aberg , et al. April 7, 1
1998-04-07
Treating urinary incontinence using (S)-desethyloxybutynin
Grant 5,677,346 - Aberg , et al. October 14, 1
1997-10-14
Methods and compositions for treating urinary incontinence using optically pure (S)-oxybutynin
Grant 5,532,278 - Aberg , et al. July 2, 1
1996-07-02
Membrane stabilizing phenoxy-piperidine compounds and pharmaceutical compositions employing such compounds
Grant 4,822,778 - Aberg , et al. April 18, 1
1989-04-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed